Improving effects of long-term growth hormone treatment on monoaminergic neurotransmission and related behavioral tests in aged rats

Rejuvenation Research

Volumn 13, Issue 6, 2010, Pages 707-716

  Esteban, Susana ^a   Garau, Celia ^a,b   Aparicio, Sara ^a   Moranta, David ^a,c   Barceló, Pere ^a   Ramis, Margarita ^a   Tresguerres, Jesús A F ^d   Rial, Rubén ^a  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Hospital Joan March   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLYASE; DOPA; DOPAMINE; GROWTH HORMONE; HUMAN GROWTH HORMONE; NEUROTRANSMITTER; NORADRENALIN; RECOMBINANT GROWTH HORMONE; SEROTONIN; TRYPTOPHAN; TYROSINE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME INHIBITION; GROWTH HORMONE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; HYDROXYLATION; IN VIVO STUDY; LEARNING DISORDER; LONG TERM CARE; MALE; MAZE TEST; MEMORY; METABOLISM; METABOLITE; MONOAMINERGIC NERVE; MOTOR COORDINATION; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RAT; ROTAROD TEST; TREADMILL; WORKING MEMORY;

5-HYDROXYTRYPTOPHAN; AGING; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; DIHYDROXYPHENYLALANINE; GROWTH HORMONE; MALE; MAZE LEARNING; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; SEROTONIN; SYNAPTIC TRANSMISSION; TIME FACTORS;

RATTUS; RATTUS NORVEGICUS;

EID: 78651311650     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2010.1053     Document Type: Article

References (70)

1. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res Dev Brain Res 1993;74:225-233.
2. Lobie PE, Zhu T, Graichen R, Goh EL. Growth hormone, insulinlike growth factor I and the CNS: Localization, function and mechanism of action. Growth Horm IGF Res 2000;10:51-56.
3. Burton KA, Kabigting EB, Clifton DK, Steiner RA. Growth hormone receptor messenger ribonucleic acid distribution in the adult male rat brain and its colocalization in hypo-thalamic somatostatin neurons. Endocrinology 1992;131: 958-963.
4. Harvey S, Lavelin I, Pines M. Growth hormone (GH) action in the brain: neural expression of a GH-response gene. J Mol Neurosci 2002;18:89-95.
5. Mustafa A, Sharma HS, Olsson Y, Gordh T, Thóren P, Sjö-quist PO, Roos P, Adem A, Nyberg F. Vascular permeability to growth hormone in the rat central nervous system after focal spinal cord injury. Influence of a new anti oxidant H 290/51 and age. Neurosci Res 1995;23:185-194.
6. Söderpalm B, Ericson M, Bohlooly M, Engel JA, Törnell J. Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry. Endocrinology 1999;140:5619-5625.
7. Hoffman AR, Leieberman SA, Ceda GP. Growth hormone therapy in the eldery: Implications for the aging brain. Psychoneuroendocrino 1992;17:327-333.
8. De Boer H, Blok GJ, van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-86.
9. Deijen JB, de Boer H, Blok GJ, van der Veen EA. Cognitive impairments and mood disturbances in growth hormone deficient men. Psychoneuroendocrinology 1996;21:313-322.
10. Aleman A, deVries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschar HP. Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiology 2000;41: 73-78.
11. Nyberg F. Growth hormone in the brain: Characteristics of specific brain targets for the hormone and their functional significance. Front Neuroendocrinol 2000;21:330-348.
12. Arwert LI, Deijen JB, Müller M, Drent ML. Long-term growth hormone treatment preserves GH-induced memory and mood improvements: A 10-year follow-up study in GH-deficient adult men. Horm Behav 2005;47:343-349.
13. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Delemarre-van deWaal HA, Drent ML. Growth hormone deficiency and memory functioning in adults visualized by functional magnetic resonance imaging. Neuroendocrinology 2005;82:32-40.
14. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Drent ML. Effects of growth hormone substitution therapy on cognitive functioning in growth hormone deficient patients: a functional MRI study. Neuroendocrinology 2006;83:12-19.
15. Cruz-Sánchez FF, Cardozo A, Castejón C, Tolosa E, Rossi ML. Aging and the nigrostriatal pathway. J Neural Transm Suppl 1997;51:9-25.
16. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science 1997;278:419-424.
17. Azcoitia I, Perez-Martin M, Salazar V, Castillo C, Ar-iznavarreta C, Garcia-Segura LM, Tresguerres JA Growth hormone prevents neuronal loss in the aged rat hippocampus. Neurobiol Aging 2005;26:697-703.
18. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.
19. Stouthart PJ, Deijen JB, Roffel M, Delemarre-van de Waal HA. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy. Psycho neuro endocrinology 2003;28:612-626.
20. Paulose CS, Balakrishnan S. Adrenergic, dopaminergic and serotonergic gene expression in low dose, long time insulin and somatotropin treatment to ageing rats: rejuvenation of brain function. Biogerontology 2008;9:429-439.
21. Burgess N, Maguire EA, O'Keefe J. The human hippocampus and spatial and episodic memory. Neuron 2002;35: 625-641. (Pubitemid 35223024)
22. Gonzalez-Burgos I, Feria-Velasco A. Serotonin/dopamine interaction in memory formation. Prog Brain Res 2008;172:603-623.
23. McNeill TH, Koek LL, Haycock JW. The nigrostriatal system and aging. Peptides 1984;5:263-268.
24. Esteban S, Garau C, Aparicio S, Moranta D, BarcelóP, Fiol MA, Rial RV. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmis-sion and related behavior in the aged rat brain. J Pineal Res 2010;48:170-177.
25. Nyberg F, Burman P. Growth hormone and its receptors in the central nervous system-Location and functional significance. Horm Res 1996;45:18-22.
26. Morrison JH, Hof PR. Selective vulnerability of corticocor-tical and hippocampal circuits in aging and Alzheimer's disease. Prog Brain Res 2002;136:467-486.
27. Rosenzweig ES, Barnes CA. Impact of aging on hippocam-pal function: plasticity, network dynamics, and cognition. Prog Neurobiol 2003;69:143-179.
28. Sousa N, Madeira MD, Paula-Barbosa MM. Structural alterations of the hippocampal formation in adrenalectomized rats: an unbiased stereological study. J Neurocytol 1997;26: 423-438.
29. Shetty AK, Turner DA. Vulnerability of the dentate gyrus to aging and intracerebroventricular administration of kainic acid. Exp Neurol 1999;158:491-503.
30. Perez-Martin M, Salazar V, Castillo C, Ariznavarreta C, Azcoitia I, Garcia-Segura LM, Tresguerres JA. Estradiol and soy extract increase the production of new cells in the dentate gyrus of old rats. Exp Gerontol 2005;40: 450-453.
31. Madsen TM, Kristjansen PE, Bolwig TG, Wortwein G. Arrested neuronal proliferation and impaired hippocampal function following fractionated brain irradiation in the adult rat. Neuroscience 2003;119:635-642.
32. Morgan DG, May PC, Finch CE. Dopamine and serotonin systems in human and rodent brain: Effects of age and neurodegenerative disease. J Am Geriatr Soc 1987;35: 334-345.
33. Smith CL, O'Malley BW. Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocr Rev 2004;25:45-71.
34. Walther DJ, Peter JU, Bashammakh S, Hörtnagl H, Voits M, Fink H, Bader M. Synthesis of serotonin by a second tryp-tophan hydroxylase isoform. Science 2003;299:76.
35. Zhang X, Beaulieu J-M, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004;305:217.
36. Sastre-Coll A, Esteban S, Miralles A, Zanetti R, Garćia-Se-villa JA. The imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline is a dopamine-releasing agent in the rat striatum in vivo. Neurosci Lett 2001;301:29-32.
37. 2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats. Naunyn-Schmiedeberg's Arch Pharmacol 2002;365: 210-219.
38. Moranta D, Esteban S, Garćia-Sevilla JA. Chronic treatment and withdrawal of the cannabinoid agonist WIN 55, 212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain. Naunyn Schmiedeberg's Arch Pharmacol 2009;379:61-72.
39. Ghigo E, Arvat E, Gianotti L, Lanfranco F, Broglio F, Ai-maretti G, Maccario M, Camami F. Hypothalamic growth hormone-insulin-like growth factor-I axis across the human life span. J Pediatr Endocrinol Metab 2000;13:1493-1502.
40. Aberg ND, Brywe KG, Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuropro-tection, regeneration, and functional plasticity in the adult brain. TheScientificWorld J 2006;6:53-80.
41. Tang JP, Melethil S. Effect of aging on the kinetics of blood- brain barrier uptake of tryptophan in rats. Pharm Res 1995;12:1085-1091.
42. Strüder HK, Weicker H. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance. Part I. Int J Sports Med 2001;22: 467-481. (Pubitemid 32980382)
43. Esteban S, Nicolaus C, Garmundi A, Rial RV, Rodŕiguez AB, Ortega E, Ibars CB. Effect of orally administered L-trypto-phan on serotonin, melatonin, and the innate immune response in the rat. Mol Cell Biochem 2004;267:39-46.
44. Fernstrom JD, Wurtman RJ. Brain serotonin content: physiological regulation by plasma neutral amino acids. Science 1972;178:414-416.
45. Garau C, Aparicio S, Rial RV, Nicolau MC, Esteban S. Age-related changes in circadian rhythm of serotonin synthesis in ring doves: Effects of increased tryptophan ingestion. Exp Gerontol 2006;41:40-48.
46. Hadsell DL, Parlow AF, Torres D, George J, Olea W. Enhancement of maternal lactation performance during prolonged lactation in the mouse by mouse GH and long-R3-IGF-I is linked to changes in mammary signaling and gene expression. J Endocrinol 2008;198:61-70.
47. Johansson J-O, Larson G, Andersson M, Elmgren A, HynsjöL, Lindahl A, Lundberg P-A, Isaksson OGP, Lindstedt S, Bengtsson B-A. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995;61:57-66.
48. Mendelsohn D, Riedel WJ, Sambeth A. Effects of acute tryptophan depletion on memory, attention and executive functions: A systematic review. Neurosci Biobehav Rev 2009;33:926-952.
49. Andersson K, Fuxe K, Eneroth P, Isaksson O, Nyberg F, Roos P. Rat growth hormone and hypothalamic catechol-amine nerve terminal systems. Evidence for rapid and discrete reductions in dopamine and noradrenaline levels and turnover in the median eminence of the hypophysectomized male rat. Eur J Pharmacol 1983;95:271-275.
50. Jiménez-Ortega V, Masternak MM, Panici JA, Wang Z, Bartke A, Esquifino AI. Effects of every-other-day feeding on prolactin regulatory mechanism in transgenic human growth hormone mice. Exp Biol Med 2008;233:434-438.
51. Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, DiMarchi R, Tschoep M, Roth RH, Gao XB, Horvath TL. Ghrelin promotes and protects ni-grostriatal dopamine function via a UCP2-dependent mito-chondrial mechanism. J Neurosci 2009;29:14057-1065.
52. Forster MJ, Dubey A, Dawson KM, Stutts WA, Lal H, Sohal RS. Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci USA 1994;93:4765-4769.
53. Bannerman DM, Rawlins JN, McHugh SB, Deacon RM, Yee BK, Bast T, Zhang WN, Pothuizen HH, Feldon J. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Biobehav Rev 2004;28:273-283.
54. Adams W, Kusljic S, van den Buuse M. Serotonin depletion in the dorsal and ventral hippocampus: effects on locomotor hyperactivity, prepulse inhibition and learning and memory. Neuropharmacology 2008;55:1048-1055.
55. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;205:929-932.
56. Luine V, Bowling D, Hearns M. Spatial memory deficits in aged rats: Contributions of monoaminergic systems. Brain Res 1990;537:271-278.
57. Sahakian BJ, Sarna GS, Kantamaneni BD, Jackson A, Huston PH, Curzon G. Association between learning and cortical catecholamines in non-drugtreated rats. Psychopharmacology 1985;86:339-343.
58. Clarke, HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. Cognititve inflexibility after prefrontal serotonin depletion. Science 2004;304:878-880.
59. Karakuyu S, Herold C, Gunturkun O, Diekamp B. Differential increase of extracellular dopamine and serotonin in the 'prefrontal cortex' and striatum of pigeons during working memory. Eur J Neurosci 2007;26:2293-2302.
60. Collier TJ, Greene JG, Felten DL, Stevens SY, Collier KS. Reduced cortical noradrenergic neurotransmission is associated with increased neophobia and impaired spatial memory in aged rats. Neurobiol Aging 2004;25:209-221.
61. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 2001;21:1628-1634.
62. Greene E, Naranjo JN. Degeneration of hippocampal fibers and spatial memory deficit in the aged rat. Neurobiol Aging 1987;8:35-43.
63. Gustafson K, Hagberg H, Bengtsson BA, Brantsing C, Isgaard J. Possible protective role of growth hormone in hypoxia- ischemia in neonatal rats. Pediatr Res 1999;45:318-323.
64. Jeay S, Sonenshein GE, Postel-Vinay MC, Kelly PA, Baixeras E. Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: New insights into signaling pathways. Mol Cell Endocrinol 2002;188:1-7.
65. Mitsunaka H, Dobashi H, Sato M, Tanaka T, Kitanaka A, Yamaoka G, Tokuda M, Matoba K, Hiraishi T, Ishida T. Growth hormone prevents Fas-induced apoptosis in lymphocytes through modulation of Bcl-2 and caspase-3. Neuroimmunomodulation 2001;9:256-262.
66. Scheepens A, Sirimanne ES, Breier BH, Clark RG, Gluckman PD, Williams CE. Growth hormone as a neuronal rescue factor during recovery from CNS injury. Neuroscience 2001;104:677-687.
67. Shin DH, Lee E, Kim J-W, Kwon B-S, Jung MK, Jee YH, Kim J, Bae S, ChangYP. Protective effect of growth hormone on neuronal apoptosis after hypoxia-ischemia in the neonatal rat brain. Neurosci Lett 2004;354:64-68.
68. Tresguerres JAF, Kireev R, Tresguerres AF, Borras C, Vara E, Ariznavarreta C. Molecular mechanisms involved in the hormonal prevention of aging in the rat. J Steroid Biochem 2008;108:318-326.
69. Tollet-Egnell P, Flores-Morales A, STáhlberg N, Malek RL, Lee N, Norstedt G. Gene expression profile of the aging process in rat liver: Normalizing effects of growth hormone replacement. Mol Endocr 2001;15:308-318.
70. Frago LM, Paneda C, Dickson SL, Hewson AK, Argente J, Chowen JA. Growth hormone (GH) and GH-releasing peptide-6 increase brain insulin-like growth factor-I expression and activate, intracellular signaling pathways involved in neuroprotection. Endocrinology 2002;143:4113-4122.